Teva Pharma AG - Sunitinib-Teva 25 mg, Hartkapseln | | 67781 | | 02 | | Sunitinib-Teva 25 mg | | Hartkapseln | | L01EX01 | | Sunitinib | | 15.02.2021 | | |
| Composition | sunitinibum 25 mg, mannitolum, povidonum K 25, carmellosum natricum conexum corresp. natrium max. 0.15 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. | Packungsbestandteile | | Capsules | | | Active Agent | Dose |
---|
Sunitinib | 25 mg |
| BAG: Active Agent | Dose |
---|
Sunitinib | 25 mg |
| | Inactive agents | Dose | additional_information |
---|
(Flavum) | | | (Nigrum) | | | (Rubrum) | | | Ammoniae Solutio Concentrata | | | Carmellosum Natricum Conexum | | | E 171 | | color. | E 172 | | color. | Gelatina | | Kapselhülle | Kalii Hydroxidum | | | Lacca | | Drucktinte | Magnesii Stearas | | | Mannitol | | | Povidonum K | 25 | | Pro Capsula | | | Propylenglycol | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
002 | 28 | 1601.50 | 1758.15 | A | SL | Yes |
|
|